DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 966 filers reported holding DANAHER CORPORATION in Q1 2015. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,508,276 | -28.2% | 42,355 | -30.6% | 0.11% | -48.8% |
| Q2 2023 | $14,640,000 | -28.7% | 61,000 | -25.1% | 0.22% | -47.3% |
| Q1 2023 | $20,528,154 | +305.0% | 81,448 | +326.5% | 0.41% | +171.1% |
| Q4 2022 | $5,068,726 | +227.2% | 19,097 | +218.5% | 0.15% | +223.4% |
| Q3 2022 | $1,549,000 | -14.1% | 5,996 | -15.7% | 0.05% | -26.6% |
| Q2 2022 | $1,803,000 | -6.9% | 7,111 | +7.7% | 0.06% | -5.9% |
| Q1 2022 | $1,936,000 | -37.7% | 6,600 | -30.1% | 0.07% | -49.6% |
| Q4 2021 | $3,107,000 | +278.0% | 9,442 | +249.7% | 0.14% | +462.5% |
| Q3 2021 | $822,000 | -11.3% | 2,700 | -21.8% | 0.02% | -14.3% |
| Q2 2021 | $927,000 | -94.6% | 3,454 | -95.5% | 0.03% | -97.0% |
| Q1 2021 | $17,151,000 | -4.4% | 76,200 | -5.7% | 0.95% | +123.3% |
| Q4 2020 | $17,946,000 | +6.3% | 80,784 | +3.0% | 0.42% | +23.2% |
| Q3 2020 | $16,881,000 | +12.0% | 78,400 | -8.0% | 0.34% | +2.1% |
| Q2 2020 | $15,066,000 | +517.0% | 85,200 | +383.0% | 0.34% | +525.9% |
| Q1 2020 | $2,442,000 | -76.9% | 17,640 | -74.4% | 0.05% | -23.9% |
| Q4 2019 | $10,572,000 | +144.9% | 68,882 | +128.1% | 0.07% | +57.8% |
| Q2 2019 | $4,316,000 | +30.2% | 30,200 | +20.3% | 0.04% | +50.0% |
| Q1 2019 | $3,314,000 | +11.8% | 25,100 | -12.7% | 0.03% | -16.7% |
| Q4 2018 | $2,965,000 | -42.4% | 28,760 | -39.3% | 0.04% | +9.1% |
| Q3 2018 | $5,150,000 | -60.0% | 47,400 | -63.7% | 0.03% | -48.4% |
| Q2 2018 | $12,887,000 | +68.7% | 130,594 | +67.4% | 0.06% | +48.8% |
| Q1 2018 | $7,637,000 | +2718.1% | 78,000 | +2364.5% | 0.04% | +72.0% |
| Q3 2017 | $271,000 | -69.3% | 3,165 | -69.8% | 0.02% | -85.1% |
| Q2 2017 | $884,000 | +44.7% | 10,478 | +46.7% | 0.17% | +40.0% |
| Q1 2017 | $611,000 | +32.0% | 7,143 | +55.8% | 0.12% | -52.4% |
| Q2 2016 | $463,000 | +41.2% | 4,586 | +19.7% | 0.25% | -9.4% |
| Q4 2014 | $328,000 | – | 3,831 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |